NVCR Q3 2021 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena

NVCRNovoCure Limited

$1B

Q3 2021 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$134M+0.7% YoY

Gross Profit

$103M77.4% margin

Operating Income

-$9M-6.4% margin

Net Income

-$13M-9.8% margin

EPS (Diluted)

$-0.13

QoQ Revenue Growth

+0.1%

Cash Flow

Operating Cash Flow

$24M

Free Cash Flow

$21M

Stock-Based Comp.

$26M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$707M

Stockholders' Equity

$413M

Cash & Equivalents

$690M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$134M	$133M	+0.7%
Gross Profit	$103M	$104M	-0.8%
Operating Income	-$9M	$15M	-156.9%
Net Income	-$13M	$9M	-241.4%

Geographic Segments

UNITED STATES

$88M66%

GERMANY

$23M17%

JAPAN

$9M7%

EMEA, Exculding Germany

$7M5%

CHINA

$7M5%